Apotheek Sevens
0840.951.002 · rovalta.com · 25/09/2026
ACTIVE
Apotheek Sevens
Financial year 2024 · Closed on 31/12/2024
Net result188,8 k €-12,6 %over 1 year
Gross margin295,2 k €+1,2 %over 1 year
Equity888,3 k €+14,0 %over 1 year
Workforce0,0 ETP
Overview
Identity
Source · BCE/KBOApotheek Sevens is a Private limited company incorporated in 2011. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Lommel.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0840.951.002
- Incorporation
- 10/11/2011
- Legal form
- Private limited company
- Registered office
- Molsekiezel 227
3920 Lommel · FlandreSee on map - Contributed capital
- 200 000,00 €
- Latest accounts
- 31/12/2024
- Average workforce
- 0,0 ETP
Activities (NACE)
Joint committees (2)
- 313
- 3130
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts
Financials
Source · NBB, 13 filingsTrend over 13 financial years
| 2024 | 2023 | 2022 | 2021 | 2020 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 295,2 k € | +1.2% | 291,7 k € | +13.4% | 257,2 k € | +6.9% | 240,6 k € | +26.6% | 190 k € |
| EBITDA | 288,8 k € | +0.6% | 287 k € | +19.2% | 240,8 k € | +39.9% | 172,1 k € | +26.0% | 136,5 k € |
| Operating result | 273 k € | +0.6% | 271,3 k € | +20.9% | 224,4 k € | +99.3% | 112,6 k € | +73.2% | 65 k € |
| Net result | 188,8 k € | -12.6% | 215,9 k € | +174% | 78,9 k € | -46.8% | 148,4 k € | +1001% | 13,5 k € |
| Balance sheet | |||||||||
| Equity | 888,3 k € | +14.0% | 778,9 k € | +32.2% | 589,3 k € | +3.7% | 568 k € | -22.4% | 732,3 k € |
| Total assets | 1,6 M € | +11.8% | 1,4 M € | +19.3% | 1,2 M € | +2.8% | 1,1 M € | -11.7% | 1,3 M € |
| Cash | 178,8 k € | +45.6% | 122,8 k € | -42.2% | 212,7 k € | -1.4% | 215,7 k € | -49.4% | 426,3 k € |
| Debts | 682 k € | +8.9% | 626,2 k € | +9.0% | 574,5 k € | +1.8% | 564,5 k € | +2.2% | 552,5 k € |
| Other | |||||||||
| Workforce | 0,0 ETP | 0,0 ETP | -100% | 1,0 ETP | 0.0% | 1,0 ETP | +25.0% | 0,8 ETP | |
Valuation
Indicative valuation
As an indication, this company is worth
between 2,5 M€ and 5 M€
See the valuationBoard of directors
Source · NBB, accounts to 31/12/20241 active · 3 ended
Active mandates
Yves Sevens
ActiveEnded mandates
Yves Sevens
EndedYVES SEVENS
EndedYves Sevens
EndedFinancials
Full financial information
Source · NBB| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 | 01/01/2019 |
| Closing of the financial year | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 | 31/12/2019 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 25/08/2025 | 18/07/2024 | 29/06/2023 | 30/08/2022 | 19/08/2021 | 21/09/2020 |
| General meeting | 20/06/2025 | 21/06/2024 | 16/06/2023 | 17/06/2022 | 18/06/2021 | 19/06/2020 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for 7 daysAnnual accounts filings
Source · NBB, 13 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2024 | 20/06/2025 | 25/08/2025 | Dutch | |
| Abridged model | 31/12/2023 | 21/06/2024 | 18/07/2024 | Dutch | |
| Abridged model | 31/12/2022 | 16/06/2023 | 29/06/2023 | Dutch | |
| Abridged model | 31/12/2021 | 17/06/2022 | 30/08/2022 | Dutch | |
| Abridged model | 31/12/2020 | 18/06/2021 | 19/08/2021 | Dutch | |
| Abridged model | 31/12/2019 | 19/06/2020 | 21/09/2020 | Dutch | |
| Abridged model | 31/12/2018 | 21/06/2019 | 16/07/2019 | Dutch | |
| Abridged model | 31/12/2017 | 15/06/2018 | 03/07/2018 | Dutch | |
| Abridged model | 31/12/2016 | 16/06/2017 | 26/06/2017 | Dutch | |
| Abridged model | 31/12/2015 | 17/06/2016 | 28/06/2016 | Dutch | |
| Abridged model | 31/12/2014 | 19/06/2015 | 29/06/2015 | Dutch | |
| Abridged model | 31/12/2013 | 20/06/2014 | 23/08/2014 | Dutch | |
| Abridged model | 31/12/2012 | 21/06/2013 | 03/07/2013 | Dutch |
Valuation
Indicative valuation
Order of magnitude
As an indication, this company is worth
between 2,5 M€ and 5 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20241 active · 3 ended
Active mandates
Yves Sevens
ActiveEnded mandates
Yves Sevens
EndedYVES SEVENS
EndedYves Sevens
EndedOwnership and network
Looking for more information about this company?
Try for 7 daysPublications
Belgian Official Gazette publications
Source · Belgian Official GazetteSimilar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2024Annual accounts 2024188,8 k €↓
- 2023Annual accounts 2023215,9 k €↑
- 2022Annual accounts 202278,9 k €↓
- 2021Annual accounts 2021148,4 k €↑
- 2020Annual accounts 202013,5 k €↓
- 2019Annual accounts 201942,8 k €↓
- 2018Annual accounts 201859,5 k €↑
- 2017Annual accounts 201726,3 k €↓
- 2016Annual accounts 201657,6 k €↑
- 2015Annual accounts 201535 k €↓
- 2014Annual accounts 201483 k €↓
- 2013Annual accounts 201385,2 k €↓
- 2012Annual accounts 2012130,9 k €
- 10/11/2011IncorporationPrivate limited company